Adjuvant aromatase inhibitor options in overweight and obese postmenopausal women with breast cancer.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California.
Rowan T
RT
Chlebowski
D000077384:Anastrozole; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D015992:Body Mass Index; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009570:Nitriles / Q000627:therapeutic use; D009765:Obesity / Q000150:complications*; D050177:Overweight / Q000150:complications*; D017698:Postmenopause; D014230:Triazoles / Q000627:therapeutic use
D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077384:Anastrozole